Rchr
J-GLOBAL ID:201801014268670040   Update date: May. 13, 2024

Yuki Yuza

ユザ ユウキ | Yuki Yuza
Affiliation and department:
Job title: Chief Consultant
Research field  (1): Fetal medicine/Pediatrics
Research theme for competitive and other funds  (3):
  • 2019 - 2023 小児生体腎のネフロン数推算方法の確立
  • 2009 - 2011 Mutation status of epidermal growth factor receptor family gene in head and neck squamous cell carcinoma and its drug-sensitivity to small molecule inhibitors.
  • 1999 - 2002 A study on release from HIA restriction in cord blood stem cell transplantation
Papers (82):
  • Akira Morimoto, Yoko Shioda, Kazuko Kudo, Hirokazu Kanegane, Toshihiko Imamura, Katsuyoshi Koh, Yoshiyuki Kosaka, Yuki Yuza, Atsuko Nakazawa, Akiko M Saito, et al. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study. International journal of hematology. 2023. 118. 1. 107-118
  • Hiroshi Hayashi, Katsuyuki Tanaka, Ayano Inui, Hiroshi Nittono, Kazuo Imagawa, Makio Kawakami, Yuki Yuza. Transient myelodysplasia triggered by parvovirus B19 infection in a male with inborn error of bile acid metabolism. Pediatric blood & cancer. 2023. e30486
  • Satoshi Miyamoto, Kevin Y Urayama, Yuki Arakawa, Katsuyoshi Koh, Yuki Yuza, Daisuke Hasegawa, Yuichi Taneyama, Yasushi Noguchi, Masakatsu Yanagimachi, Takeshi Inukai, et al. Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia. Pediatric hematology and oncology. 2023. 1-7
  • Masanori Yoshida, Kazuhiko Nakabayashi, Wentao Yang, Aiko Sato-Otsubo, Shin-Ichi Tsujimoto, Hiroko Ogata-Kawata, Tomoko Kawai, Keisuke Ishiwata, Mika Sakamoto, Kohji Okamura, et al. Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers. Cancer medicine. 2023. 12. 10. 11264-11273
  • Masahiro Irie, Tetsuya Niihori, Tomohiro Nakano, Tasuku Suzuki, Saori Katayama, Kunihiko Moriya, Hidetaka Niizuma, Nobu Suzuki, Yuka Saito-Nanjo, Masaei Onuma, et al. Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome. International journal of hematology. 2023. 117. 4. 598-606
more...
MISC (69):
  • 大園 秀一, 湯坐 有希, 松本 公一, 大賀 正一. 【成人患者における小児期発症慢性疾患】各専門領域における小児期発症慢性疾患の成人移行支援の取り組みの現状 血液/腫瘍・小児がん. 小児内科. 2022. 54. 9. 1489-1491
  • 大園 秀一, 石田 也寸志, 前田 美穂, 大植 孝治, 上別府 圭子, 清谷 知賀子, 竹之内 直子, 長 祐子, 湯坐 有希, 家原 知子, et al. 小児期発症血液・腫瘍性疾患の成人への移行期支援に関する基本的姿勢. 日本小児血液・がん学会雑誌. 2022. 59. 1. 58-65
  • 佐藤 聡美, 瀧本 哲也, 小阪 嘉之, 佐藤 篤, 湯坐 有希, 康 勝好, 角南 勝介, 種山 雄一, 堀 壽成, 太田 節雄, et al. 小児急性リンパ性白血病患児における認知機能の前方視的多施設協同研究. 日本小児血液・がん学会雑誌. 2022. 58. 5. 424-431
  • 横川 裕一, 牧本 敦, 松井 基浩, 鈴木 喬悟, 峰岸 英博, 増田 早織, 湯坐 有希. 小児急性リンパ性白血病の標準治療確立を目指した臨床研究 TMC-ALL01結果報告. 東京都福祉保健医療学会抄録. 2021. 17回. 40-41
  • 嶋 晴子, 佐藤 伊織, 上別府 圭子, 嘉田 晃子, 谷澤 昭彦, 遠野 千佳子, 伊藤 正樹, 渡辺 輝浩, 湯坐 有希, 瓜生 英子, et al. 長期TKI治療後の小児CML患者における無治療寛解の効果(Impact of TFR on adverse events and QOL in children with long-term exposure to TKI for CML). 日本血液学会学術集会. 2021. 83回. OS1-5
more...
Professional career (2):
  • Doctor of Philosophy (The Jikei University)
  • Doctor of Medicine (Yamagata University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page